X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (443) 443
Paper (104) 104
Publication (74) 74
Patent (20) 20
Report (7) 7
Conference Proceeding (1) 1
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (148) 148
experiment (111) 111
particle physics (104) 104
physics - high energy physics - experiment (100) 100
high energy physics - experiment (99) 99
physics (99) 99
female (98) 98
male (96) 96
adult (85) 85
middle aged (80) 80
high energy physics (65) 65
aged (61) 61
index medicus (53) 53
cern lhc coll (52) 52
child (52) 52
adolescent (51) 51
experimental results (51) 51
phenomenology (51) 51
japan (47) 47
child, preschool (44) 44
infectious diseases (42) 42
scattering [p p] (42) 42
8000 gev-cms (41) 41
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (41) 41
colliding beams [p p] (41) 41
influenza (40) 40
physical sciences (35) 35
fysik (34) 34
infant (33) 33
aged, 80 and over (32) 32
oseltamivir (31) 31
influenza, human - virology (29) 29
particle physics - experiment (28) 28
immunology (27) 27
influenza, human - drug therapy (27) 27
physics of elementary particles and fields (27) 27
pharmacology & pharmacy (24) 24
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (22) 22
antiviral agents - therapeutic use (22) 22
japan - epidemiology (22) 22
natural sciences (21) 21
naturvetenskap (21) 21
nuclear experiment (21) 21
gastroenterology & hepatology (20) 20
medicine & public health (18) 18
molecular sequence data (18) 18
young adult (18) 18
zanamivir (18) 18
age factors (17) 17
base sequence (17) 17
hadron-hadron scattering (17) 17
hematology, oncology and palliative medicine (17) 17
human necessities (17) 17
influenza, human - epidemiology (17) 17
oncology (17) 17
efficacy (16) 16
laninamivir (16) 16
neuraminidase - antagonists & inhibitors (16) 16
cancer (14) 14
diagnosis (14) 14
engineering (14) 14
multicenter (14) 14
physics and astronomy (14) 14
physics, particles & fields (14) 14
safety (14) 14
science & technology (14) 14
subatomic physics (14) 14
subatomär fysik (14) 14
background (13) 13
care and treatment (13) 13
ciências físicas [ciências naturais] (13) 13
endoscopy (13) 13
fever (13) 13
infant, newborn (13) 13
influenza a virus, h3n2 subtype - drug effects (13) 13
neuraminidase inhibitor (13) 13
treatment outcome (13) 13
viruses (13) 13
zanamivir - therapeutic use (13) 13
agriculture (12) 12
animal husbandry (12) 12
colorectal cancer (12) 12
cultivation of vegetables, flowers, rice, fruit, vines, hopsor seaweed (12) 12
fishing (12) 12
forestry (12) 12
hepatitis b virus (12) 12
horticulture (12) 12
hunting (12) 12
inhibitory concentration 50 (12) 12
internal medicine (12) 12
trapping (12) 12
watering (12) 12
amino acid sequence (11) 11
antibodies (11) 11
antiviral agents - pharmacology (11) 11
hepatitis b - epidemiology (11) 11
hepatitis b - immunology (11) 11
hepatitis b surface antigens - analysis (11) 11
infection (11) 11
influenza, human - prevention & control (11) 11
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (444) 444
Japanese (28) 28
French (6) 6
German (3) 3
Chinese (2) 2
Korean (1) 1
Portuguese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Expert Review of Anti-Infective Therapy, ISSN 1478-7210, 10/2011, Volume 9, Issue 10, pp. 851 - 857
Oseltamivir and zanamivir are well-established and well-researched drugs for the treatment of influenza in Japan and the rest of the world. A new neuraminidase... 
influenza | neuraminidase inhibitor | inhale | single administration | laninamivir | long acting | MULTICENTER | SINGLE | EFFICACY | SAFETY | OSELTAMIVIR | PRODRUG | DOUBLE-BLIND | CS-8958 | PHARMACOLOGY & PHARMACY | Influenza A Virus, H5N1 Subtype - enzymology | Prodrugs - administration & dosage | Antiviral Agents - pharmacokinetics | Influenza A Virus, H3N2 Subtype - drug effects | Humans | Influenza in Birds - prevention & control | Influenza in Birds - immunology | Caprylates - metabolism | Viral Proteins - metabolism | Enzyme Inhibitors - administration & dosage | Zanamivir - analogs & derivatives | Zanamivir - pharmacokinetics | Adult | Influenza in Birds - drug therapy | Influenza, Human - virology | Influenza B virus - drug effects | Influenza, Human - drug therapy | Child | Virus Replication - drug effects | Influenza A Virus, H3N2 Subtype - enzymology | Antiviral Agents - therapeutic use | Japan | Administration, Inhalation | Neuraminidase - metabolism | Birds | Viral Proteins - antagonists & inhibitors | Influenza A Virus, H5N1 Subtype - drug effects | Influenza A Virus, H1N1 Subtype - drug effects | Influenza B virus - physiology | Antiviral Agents - administration & dosage | Caprylates - chemistry | Enzyme Inhibitors - therapeutic use | Zanamivir - therapeutic use | Animals | Prodrugs - pharmacokinetics | Influenza A Virus, H1N1 Subtype - enzymology | Oseltamivir - administration & dosage | Influenza in Birds - virology | Zanamivir - administration & dosage | Drug Resistance, Viral - drug effects | Neuraminidase - antagonists & inhibitors | Prodrugs - therapeutic use | Influenza, Human - prevention & control | Influenza, Human - immunology
Journal Article
Journal of Infection and Chemotherapy, ISSN 1341-321X, 03/2018, Volume 24, Issue 3, pp. 193 - 198
Genetic variation of influenza neuraminidase (NA), unlike for hemagglutinin (HA), has not been fully characterized. Therefore, we determined the relation... 
Co-mutation | Hemagglutinin | Influenza | Neuraminidase
Journal Article
Journal Article
Influenza and Other Respiratory Viruses, ISSN 1750-2640, 03/2019, Volume 13, Issue 2, pp. 115 - 122
Background The large consumption of neuraminidase inhibitors (NAIs) for the treatment of influenza virus infections places Japan at risk of becoming the... 
influenza | mutation | neuraminidase inhibitor | neuraminidase | resistance | SITE | INFECTIOUS DISEASES | VIRUS | SUSCEPTIBILITY | GLOBAL UPDATE | SEASON | VIROLOGY | OSELTAMIVIR-RESISTANT | CLUSTER | Epidemics | Health risks | Amino acids | Viruses | High resistance | Kinases | Zanamivir | Oseltamivir | Inhibitors | Active sites | Exo-a-sialidase | Influenza | Mutation | Catalysis | Seasons | Original
Journal Article
Journal of Infection and Chemotherapy, ISSN 1341-321X, 03/2019, Volume 25, Issue 3, pp. 222 - 224
MDCK-induced amino acid (AA) mutation, such as D151G/N in the neuraminidase (NA) of influenza A/H3N2 viruses, is of concern. MDCK-SIAT1 cells, modified... 
Deep sequencing | Mutation | Influenza | MDCK-SIAT1 | CELLS | INFECTIOUS DISEASES | PHARMACOLOGY & PHARMACY
Journal Article
Otolaryngology - Head and Neck Surgery (Japan), ISSN 0914-3491, 10/2014, Volume 86, Issue 11, pp. 904 - 909
Journal Article
Journal Article
Journal Article